Gluten Sensitivity
Conditions
Keywords
gluten sensitivity, gluten-free diet, FODMAP diet, microbiome
Brief summary
Patients with non-celiac gluten sensitivity (NCGS) complain about gastrointestinal and extraintestinal symptoms while consuming gluten-containing cereals. The symptoms strictly correlate with ingestion of gluten-containing cereals and disappear quickly under elimination diets. Till now, there are no specific markers to diagnose NCGS. This study aims to determine the effect of a low FODMAP diet (fermentable oligo-, di- and monosaccharides and polyols) and a glutenfree diet on the mucosal immunity, clinical symptoms, and psychological well-being. Furthermore, the influence of the diets on the microbiome will be analyzed.
Detailed description
Patients with gluten-sensitivity are rigourously checked for wheat allergy and celiac disease. Genotyping for DQ2/8, serological detection of celiac specific antibodies, and gastroduodenoscopy are performed. Furthermore, a skin prick test and detection of wheat specific IgE are done. After exclusion of celiac disease and wheat allergy patients are considered as patients with NCGS. Patients and healthy controls are asked to consume a low FODMAP diet for two weeks, followed by a 5 day washout and subsequent two week gluten-free diet. At the beginning and the end of each diet the participants fill in questionnaires concerning Nutrition (Freiburger Nutrition protocol), psychological well-being index (PGWB), gastrointestinal symptom Rating score (GSRS), and stool consistency (Bristol stool Chart). Furthermore, stool samples are selected at each time point to determine the microbial pattern. NCGS patients with ongoing complaints will have a second gastroduodenoscopy at the end of the study.
Interventions
2 week FODMAP low diet
2 week gluten-free diet
Sponsors
Study design
Intervention model description
Participants consume a two week lasting low FODMAP diet, followed by 5 days washout, and subsequent two week gluten-free diet.
Eligibility
Inclusion criteria
* healthy controls * patients with glutensensitivity
Exclusion criteria
* patients with glutensensitivity but without celiac disease or wheat allergy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Determination of clinical symptomatics | 2 weeks | Analysis of the improvement of clinical symptoms according to gastrointestinal symptom Rating score |
| Determination of psychological symptoms | 2 weeks | Improvement of well-being by questionnaire psychological General well-being index |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Nutrition Analysis for energy intake and nutritional composition by questionnaire Freiburger Nutrition protocol | 2 weeks | Determination of nutrient intake according to questionnaire Freiburger Nutrition protocol. The questionnaire allows the detailed determination of energy intake, carbohydrates, fatty acids, and Protein. |
| Intraepithelial lymphocytes | 4 weeks | numbers of intraepithelial lymphocytes in duodenal mucosa |
| Goblet cells | 4 weeks | numbers of Goblet cells in duodenal mucosa |
| microbiome | 2 weeks | Analysis of microbiota pattern |
Countries
Germany